William Blair investment banking managing director Kevin Eisele was quoted in healthcare industry trade publication Endpoints News, where he discussed the drivers behind M&A activity for big pharma.
“It’s natural to assume that if [companies are] watching the best assets consistently getting taken off the market that they’re going to accelerate their own decision-making and be more proactive,” Eisele said.